Trending
Man jailed for fatally shooting cousin at wake in HammersmithPressure mounts on Gov. McKee to flex his veto power on these billsLanguage gaps in courts risk denying fair justice - UNIMACSadiq Khan accused of misleading Londoners over TfL fare evasion crackdownChick-Fil-A Has Officially Been Dethroned As America's Top-Rated Fast Food ChainTakeaways From ‘Regime Change,’ Maggie Haberman and Jonathan Swan’s Book on Trump’s White HouseNext year to be Apple’s ‘biggest product year’ ever, here’s what’s comingMotorola Razr Fold in for reviewBuilding A 2-Way Holographic DisplayTrump administration reverses plans to ditch a critical ocean monitoring system after furious bipartisan backlashEx-MP Naresh Gujral loses Rs 7.8cr to cyber crooks who digitally impersonate him'I Cheated on My Wife' Former congressional candidate admits to 2022 affairJPMorganChase blocks Hong Kong staff from using ClaudeTrump Mocked Mark Zuckerberg and Jeff Bezos by Showing Off Fawning TextsRethinking Seafood: How our partnership with WWF is helping to build a more sustainable future for our oceansThe 16 best earbuds early Prime Day deals: Noise-cancelling and open earbudsRotating brain waves uncover circular sensory circuits linked to movement and sensationMivo’s new app takes a mindful approach to managing screen timeMan jailed for fatally shooting cousin at wake in HammersmithPressure mounts on Gov. McKee to flex his veto power on these billsLanguage gaps in courts risk denying fair justice - UNIMACSadiq Khan accused of misleading Londoners over TfL fare evasion crackdownChick-Fil-A Has Officially Been Dethroned As America's Top-Rated Fast Food ChainTakeaways From ‘Regime Change,’ Maggie Haberman and Jonathan Swan’s Book on Trump’s White HouseNext year to be Apple’s ‘biggest product year’ ever, here’s what’s comingMotorola Razr Fold in for reviewBuilding A 2-Way Holographic DisplayTrump administration reverses plans to ditch a critical ocean monitoring system after furious bipartisan backlashEx-MP Naresh Gujral loses Rs 7.8cr to cyber crooks who digitally impersonate him'I Cheated on My Wife' Former congressional candidate admits to 2022 affairJPMorganChase blocks Hong Kong staff from using ClaudeTrump Mocked Mark Zuckerberg and Jeff Bezos by Showing Off Fawning TextsRethinking Seafood: How our partnership with WWF is helping to build a more sustainable future for our oceansThe 16 best earbuds early Prime Day deals: Noise-cancelling and open earbudsRotating brain waves uncover circular sensory circuits linked to movement and sensationMivo’s new app takes a mindful approach to managing screen time

Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay

POWAY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Di...

News Desk

Staff Writer

Published

Jun 19, 2026

Source

The Manila Times

Analytics

0 0 0
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay

AI Insight:This clearance marks a significant step forward in the diagnosis and management of cardiovascular disease.

Diazyme Laboratories, Inc. has secured FDA 510(k) clearance for its Lipoprotein(a) Molarity Assay, a crucial development in the field of cardiovascular diagnostics. The assay is designed to measure lipoprotein(a), a known risk factor for cardiovascular disease, which can lead to conditions such as atherosclerosis, heart attacks, and strokes. The FDA clearance enables Diazyme Laboratories to market and distribute the assay, making it available to healthcare professionals for use in clinical settings. This development is expected to improve the accuracy and efficiency of cardiovascular disease diagnosis and management, ultimately contributing to better patient outcomes. The Lipoprotein(a) Molarity Assay is a significant addition to Diazyme Laboratories' portfolio of diagnostic solutions, solidifying its position as a leading provider of innovative laboratory testing products.